Randomized controlled trial of remimazolam compared with placebo in Japanese patients undergoing upper gastrointestinal endoscopy: Phase III investigator-initiated clinical trial.

Ryoji IchijimaHisatomo Ikehara Daisuke YamaguchiYasuhiko NagataKanako OguraMitsuru Esaki Yosuke MinodaHiroyuki OnoYuki MaedaShinsuke KiriyamaTetsuya SumiyoshiYuichi KanmuraTakuji Gotoda

Published in: Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society (2024)

Remimazolam demonstrated a significantly higher sedation effect during upper gastrointestinal endoscopy in Japanese patients with safe and fast recovery compared with placebo.

Keyphrases

phase iii
clinical trial
open label
randomized controlled trial
patients undergoing
double blind
study protocol
small bowel
phase ii
placebo controlled
intensive care unit